FDA designates Boston Scientific catheter issue as Class I recall

AI-generated NewsSnap summary based on source reporting.
Published: 2026-08-26
Category: health
Source: U.S. Food and Drug Administration
Original source

The U.S. Food and Drug Administration (FDA) has classified an issue with Boston Scientific's ENROUTE Transcarotid Neuroprotection System as a Class I Recall. This classification indicates a reasonable probability that using the affected products could lead to serious adverse health consequences or death, necessitating public awareness and updated product identification.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai